Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Multiple Myeloma 6Neoplasm Metastasis 4Carcinoma 4Breast Neoplasms 4Neoplasms 3Melanoma 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Glioma 2Fallopian Tube Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Unspecified Childhood Solid Tumor, Protocol Specific 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Ras-mutated Metastatic Colorectal Cancer 1Prostatic Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Glioblastoma 1Fibrosarcoma 1Diffuse Intrinsic Pontine Glioma 1

Interventions

Doxorubicin 17Ifosfamide 16Radiotherapy 10Filgrastim 5Imatinib Mesylate 4Etoposide 4Chemotherapy, Adjuvant 4pazopanib 3Vincristine 3Neoadjuvant Therapy 3Dactinomycin 3Cyclophosphamide 3Carboplatin 3pegfilgrastim 2cixutumumab 2brostallicin 2belinostat 2Trabectedin 2Sunitinib 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Epirubicin 2Diathermy 2temsirolimus 1soblidotin 1selinexor 1saracatinib 1romidepsin 1ribociclib 1reolysin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosarcoma × reolysin × Clear all
NCT00503295 2014-10-02

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

Oncolytics Biotech

Phase 2 Completed
53 enrolled
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡